Improving communication about sexual health for women after gynecologic cancer treatment
Official title: Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention
Funded at Research Inst of Fox Chase Can Ctr · NIH-10981519 · Data updated 2026-11-12
This study is designed to help women who have been treated for gynecologic cancer talk more openly about their sexual health with their doctors, using a special program called Starting the Conversation – Gynecologic Cancer, to make these important discussions easier and less stressful.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $475,317 |
| NIH project number | 1R01CA285674-01A1 |
| Project ID | NIH-10981519 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women who have been treated for gynecologic cancer and are experiencing sexual health concerns.
✕Less likely to help
Patients who are not experiencing sexual health concerns or who have not been treated for gynecologic cancer may not benefit from this research.
What this research studies
This research focuses on helping women who have undergone treatment for gynecologic cancer to effectively communicate their sexual health concerns with their healthcare providers. It utilizes a modified intervention called Starting the Conversation – Gynecologic Cancer (STC-GC), which empowers patients to initiate discussions about their sexual health needs. The study will involve 200 female patients who will be randomly assigned to receive this intervention, aiming to evaluate its effectiveness in improving communication and addressing sexual health issues. By enhancing patient-provider communication, the research seeks to reduce the distress associated with sexual health concerns post-treatment.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for women after gynecologic cancer by facilitating better communication about sexual health issues.
How similar studies have gone: Previous research has shown that similar interventions have been effective in improving communication about sexual health in breast cancer patients, suggesting potential success in this modified approach for gynecologic cancer patients.
Where this research is happening
-
Research Inst of Fox Chase Can Ctr
Philadelphia, United States Active
Researchers
- Principal investigator: Reese, Jennifer Barsky — Research Inst of Fox Chase Can Ctr
- Study coordinator: Reese, Jennifer Barsky
Related research
Other NIH-funded projects on the same topics.
-
Promoting open talks about sexual health after gynecologic cancer
A patient-focused program helps women with gynecologic cancer start and guide conversations about sexual health with their doctors.
-
Improving Conversations About Sexual Health After Gynecologic Cancer
This project helps women who have had gynecologic cancer feel more confident and prepared to talk with their doctors about sexual health concerns.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.